According to data from Benzinga Pro, during Q4, Establishment Labs Hldgs's (NASDAQ:ESTA) reported sales totaled $35.31 million. Despite a 3.32% increase in earnings, the company posted a loss of $14.19 million.
Establishment Labs Hldgs (NASDAQ:ESTA) reported its Q4 earnings results on Tuesday, March 1, 2022 at 08:00 AM.
Here's what investors need to know about the announcement.
Establishment Labs Hldgs (NASDAQ:ESTA) is set to give its latest quarterly earnings report on Tuesday, 2022-03-01. Here's what investors need to know before the announcement.
Analysts estimate that Establishment Labs Hldgs will report an earnings per share (EPS) of $-0.33.
Establishment Labs' unaudited preliminary revenue for the fourth quarter of 2021 is expected to be in the range of $35.0 million to $35.5 million, an increase
Establishment Labs Holdings Inc. (NASDAQ:ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, today announced that Juan
Establishment Labs Hldgs (NASDAQ:ESTA) reported quarterly losses of $(0.61) per share which missed the analyst consensus estimate of $(0.35) by 74.29 percent. This is a 238.89 percent decrease over losses of $(0.18) per
Companies Reporting Before The Bell
• Imara (NASDAQ:IMRA) is projected to report earnings for its third quarter.
• KT (NYSE:KT) is projected to report earnings for its third quarter.